Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Repatha (Amgen)
(https://repatha.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab) (https://repatha.com)
High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab)
Learn about how Repatha® helps to reduce risk of a heart attack & lower high bad cholesterol for adults at increased risk of a major cardiovascular event. See Full Safety & Prescribing Info.
NAV_HEADER_REPEATED_BODY What is Repatha® (evolocumab)? (https://repatha.com/what-is-repatha/)
What is Repatha® (evolocumab)?
Learn what Repatha® is and how it can dramatically lower bad cholesterol (LDL-C) & reduce risk of a heart attack for adults at increased risk of a major cardiovascular event. See Full Safety & Prescribing Info.
NAV_HEADER_HEADING_REPEATED_FOOTER Amgen® SupportPlus Enrollment | Repatha® (evolocumab) (https://repatha.com/enrollment/)
Amgen® SupportPlus Enrollment | Repatha® (evolocumab)
Enroll in Amgen® SupportPlus to access financial support and helpful resources to help you through your Repatha® (evolocumab) treatment. See Full Prescribing & Safety Info
HEADING_REPEATED_BODY Repatha® (evolocumab) Co-Pay Card Terms & Conditions (https://repatha.com/copaytcs/)
Repatha® (evolocumab) Co-Pay Card Terms & Conditions
Find full terms and conditions for the Repatha® Co-Pay Card. See Full Prescribing & Safety info.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://repatha.com) High Bad Cholesterol (LDL-C) Treatment | Repatha® (evolocumab)
Close [H3] [H1] Important Safety Information Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex. Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take. What are the possible side effects of Repatha®? Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms. The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. [H3] APPROVED USE What is Repatha®? Repatha® is an injectable prescription medicine used: to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events. Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH). Please see full Prescribing Information, including Patient Product Information. Open [H5] IMPORTANT SAFETY INFORMATION Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
SUB-PAGE (https://repatha.com/what-is-repatha/) What is Repatha® (evolocumab)?
What Is Repatha®?Repatha® is a breakthrough medicine that can help you dramaticallylower bad (LDL) cholesterol and reduce your risk of heart attack. [H4] Why Repatha®? [H3] BECAUSE YOU’RE HUMAN [IMG: Robot] This is Sam. He does not have high bad cholesterol. He also performs tasks perfectly. When trying to lower your cholesterol, you’re expected to be perfect—like Sam. And if you don’t swap a steak for a salad or you feel like watching your favorite TV show instead of exercising, you may feel judgment from the people who matter most to you. But unlike Sam, you’re human. And although you do your best to exercise and maintain a healthy diet, you also want to experience the joy of what makes you human. With help from Repatha®, you can lower your bad cholesterol while you enjoy life. Because You’re Human. Every heart has its own story. Whether you’ve already had a heart attack or stroke or are working to reduce the risk of having one, Repatha® can help protect your heart from a major cardiovascular event, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery. Help lower your LDL-C and your risk of another heart attack or stroke with Repatha® Help lower your LDL-C and risk of a first heart attack with Repatha® In a study of adults with cardiovascular disease taking statins, Repatha® was shown to help by: Repatha® starts working quickly. In just 2 weeks, it starts working to bring LDL-C down, with a [H2] 63% average reduction in just 3 months. [H2] 84% of patients lowered high LDL-C to below 55 mg/dL in 1 month. Everyone's recommended LDL-C level may be different. Talk to your doctor about what is right for you. Proven to cut risk of a heart attack by [H2] 27% Patients not treated with Repatha® had more heart attacks (4.6%) compared to those treated with Repatha® (3.4%). Proven to cut risk of a stroke by [H2] 21% Patients not treated with Repatha® had more strokes (1.9%) compared to those treated with Repatha® (1.5%). Talk to your doctor about reducing your risk of a major cardiovascular event. DOWNLOAD DOCTOR DISCUSSION GUIDE In a study of adults at increased cardiovascular risk, who did not have a history of heart attack or stroke, and who may have already been on an additional LDL-C lowering treatment,* Repatha® was shown to help by: *Any dose of statin with or without ezetimibe. Repatha® lowered LDL-C by [H2] 55% [IMG: Diagram showing LDL-C level reduction after treatment] Results from a subset of the study measured how much LDL-C was lowered over 48 weeks. Repatha® cut risk of a first heart attack by [H2] 36% Patients not treated with Repatha® had more heart attacks (4.1%) compared to those treated with Repatha® (2.7%). Talk to your doctor about reducing your risk of a major cardiovascular event. DOWNLOAD DOCTOR DISCUSSION GUIDE [H2] 10 Years of Impact. Over 5 Million Patients Served Worldwide.* Still Committed to Lowering LDL-C. *Cumulative post-market exposure estimates from July 2015 through July 2025, on patients that have received at least 1 dose (estimates assume administration) of the product, which was estimated using prescription claims data (IQVIA) for the U.S. and units distributed (Amgen Finance Electronic Data Warehouse) with average drug utilization patterns (MarketScan claims data) for all other regions. Utilization assumptions were applied to calculate the unique number of patients. [IMG: Headshot of Repatha® (evolocumab) Patient, Cathy] “ With Repatha®, my LDL-C had dropped from over 100, down to 40.” – CATHY, a real Repatha® patient who had a heart attack HEAR MORE SUCCESS STORIES Individual results may vary. Repatha® Works Differently From a Statin Take a look at this video that explains bad cholesterol and how to get yours down with Repatha®. You've listened to your heart—now give it a voice. [IMG: discussion-guide-v2] It's important to talk to your doctor about your LDL-C. Not sure what to say? Our Doctor Discussion Guide can help you set goals and feel more supported as you head into that conversation. You can download this guide, and consider bringing it to your next appointment. [IMG: Illustration of cartoon heart pointing to the left] DOWNLOAD GUIDE I'VE HAD A HEART ATTACK Jerry and his heart don't always agree. So when it came to Repatha®, they talked it out. Here's what happened. Repatha® is also for people with an inherited condition that causes high bad cholesterol (called familial hypercholesterolemia, or FH), who still need to lower their bad cholesterol even though they diet and exercise. For some people, poor diet, overweight/obesity, or low level of physical activity might not be the primary cause of high LDL-C. Sometimes high LDL-C is caused by an inherited condition called FH. Heterozygous FH (HeFH) represents one form of this common genetic disorder that affects the liver’s ability to remove excess LDL-C. HeFH is an inherited condition, which means it is caused by an abnormal gene that can be passed down from one of the parents. This can lead to premature cardiovascular disease, as well as other complications caused by high LDL-C. Repatha® + a statin lowered LDL-C around an average of 60%.† Repatha® drives LDL-C down in people with HeFH. †Results from a study at week 12 compared to a placebo. Some patients were also on other cholesterol-lowering therapies. Repatha® was taken every 2 weeks or once monthly. Your results may vary. Close [H3] [H1] Important Safety Information Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex. Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take. What are the possible side effects of Repatha®? Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms. The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. [H3] APPROVED USE What is Repatha®? Repatha® is an injectable prescription medicine used: to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events. Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH). Please see full Prescribing Information, including Patient Product Information. Open [H5] IMPORTANT SAFETY INFORMATION Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
SUB-PAGE (https://repatha.com/enrollment/) Amgen® SupportPlus Enrollment | Repatha® (evolocumab)
Close [H3] [H1] Important Safety Information Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex. Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take. What are the possible side effects of Repatha®? Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms. The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. [H3] APPROVED USE What is Repatha®? Repatha® is an injectable prescription medicine used: to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events. Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH). Please see full Prescribing Information, including Patient Product Information. Open [H5] IMPORTANT SAFETY INFORMATION Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
SUB-PAGE (https://repatha.com/copaytcs/) Repatha® (evolocumab) Co-Pay Card Terms & Conditions
Close [H3] [H1] Important Safety Information Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Repatha® is available as prefilled single-dose SureClick® autoinjectors and prefilled single-dose syringes that either contain dry natural rubber (a derivative of latex) in the needle cover or are not made with natural rubber latex. The carton and “Instructions for Use" in the carton will state if your prefilled single-dose SureClick® autoinjector or prefilled single-dose syringe contains dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex. Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take. What are the possible side effects of Repatha®? Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms. The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. [H3] APPROVED USE What is Repatha®? Repatha® is an injectable prescription medicine used: to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest pain conditions (unstable angina) requiring hospitalization, or certain types of heart surgery, in adults at increased risk for these events. Along with diet and exercise to reduce low-density lipoprotein (LDL) or bad cholesterol in adults with high blood cholesterol levels called hypercholesterolemia and in adults with a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH). Please see full Prescribing Information, including Patient Product Information. Open [H5] IMPORTANT SAFETY INFORMATION Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®. Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /what-is-repatha/ | 2 | 0 |
| /enrollment/ | 4 | 0 |
| /copaytcs/ | 3 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Repatha (Amgen) (repatha.com)
Repatha offers a substantive medical product packaged in an overly engineered ‘human-centric’ marketing shell. While the clinical data is robust and likely scientifically accurate, the site’s reliance on unverified patient stories and a total lack of structured data schema creates a measurable distance between its regulatory signal and its digital substance.
Replace the vague [H1] ‘Repatha® can help’ with a substance-led heading like ‘Repatha®: 63% Average LDL-C Reduction in 3 Months.’ Implement comprehensive Product and MedicalWebPage schema to bridge the technical authority gap. Add direct outbound citations to the peer-reviewed publications for the FOURIER or cardiovascular outcomes trials mentioned. Replace the robotic Sam metaphor with a technical ‘Mechanism of Action’ section to increase expert-level information density.
The site perfectly matches the Pharma & Biotech industry, evidenced by extensive ‘Important Safety Information’ blocks, ‘Approved Use’ declarations, and specific clinical data metrics for evolocumab. It follows high-compliance regulatory patterns typical of FDA-regulated prescription medication pages.
“The score of 39 is driven primarily by the Commodity Fingerprint (11) and Trust Theatre (8) pillars. While the site is medically substantive, its marketing delivery is highly derivative of standard pharma templates and it fails to provide verifiable links for its patient reviews or implement modern technical authority signals (Schema).”
This training module utilizes a snapshot of public data from Repatha (Amgen), captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Repatha (Amgen): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://repatha.com to view the most current version of its content and learn from the source what this company is about and what it offers.